Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIO-Asia: Rimonabant in Obese Patients
NCT00325546Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of rimonabant in obesity, sponsored by Sanofi. Started Apr 2006; status: completed.
02
Drugs
rimonabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00325546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325546.